Fertiliti Joins Forces with Dr. Celalettin Peru, a Pioneer in Male Infertility Treatment and Azoospermia Specialist

Istanbul, Turkey — November 18, 2023

In a significant leap toward transforming male infertility treatment, Fertiliti, a leading figure in reproductive health solutions, has formed a strategic alliance with Dr. Celalettin Peru, a distinguished internal medicine specialist renowned for his expertise in treating male infertility, specifically focusing on challenging cases of azoospermia, including Sertoli Cell syndrome.

Dr. Peru's specialization revolves around treating intricate azoospermia cases, wherein strong evidence indicates that hormonal treatment plays a pivotal role in enhancing success rates for surgical procedures like TESE (Testicular Sperm Extraction), mTESE (Microdissection Testicular Sperm Extraction), among others. There's growing acknowledgment among urologists worldwide of the significance of initiating hormonal treatment before considering invasive surgeries for azoospermia, as rushing into surgical interventions can potentially reduce the likelihood of locating viable sperm.

"Partnering with Dr. Celalettin Peru signifies our commitment to advancing male fertility treatment through innovative approaches that prioritize hormonal treatments and supplements," stated Dr. Jennifer Lee, Chief Medical Officer at Fertiliti. "His unique approach to treating azoospermia has demonstrated remarkable success rates, making him an invaluable addition to our mission."

Dr. Peru's treatment methodology, rooted in his firm belief that a combination of hormonal treatment and tailored supplements can address the majority of azoospermia cases, has garnered significant attention. His personal experience with male infertility has propelled him to assist men globally facing similar challenges, aiming to minimize reliance on surgical interventions whenever possible.

"I am dedicated to offering alternatives to surgery for azoospermia cases, advocating for a treatment approach that incorporates hormonal therapy and supplements," commented Dr. Celalettin Peru. "My goal is to alleviate the burden of infertility by providing effective solutions that prioritize non-invasive methods, ensuring surgeries are considered as a last resort."

Dr. Peru's treatment philosophy emphasizes exhaustively exploring hormonal therapies and supplementary regimes before considering surgical interventions. However, in instances where hormonal and supplement therapies fall short, surgical options are considered as a final recourse.

Having successfully treated thousands of patients globally and boasting high treatment success rates, Dr. Peru actively participates in Fertiliti's "Ask Me Anything" forums, imparting guidance on azoospermia cases each week, extending his support to individuals worldwide grappling with male infertility.

This collaboration between Fertiliti and Dr. Celalettin Peru represents a paradigm shift in addressing male infertility, emphasizing the importance of non-surgical approaches in treating azoospermia cases and offering hope to men navigating fertility challenges.

For additional information on the partnership and forthcoming initiatives, visit Fertiliti's official website at www.fertiliti.io.

Press Contact:

Name: Sophia Richardson

Title: Communications Director

Email: support@fertiliti.io

Phone: +1-438-878-9711